Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 10:19 PM
Study NCT ID:
NCT01169558
Status:
COMPLETED
Last Update Posted:
2016-12-08
First Post:
2010-07-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-22
First Submit QC Date:
None
Study First Post Date:
2010-07-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-25
Results First Submit QC Date:
None
Results First Post Date:
2016-10-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-26
Last Update Post Date:
2016-12-08
Last Update Post Date Type:
ESTIMATED